Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check25 days agoChange DetectedA site-wide NIH announcement says federal agencies are transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms potentially appearing during the transition.SummaryDifference0.8%

- Check31 days agoChange DetectedThe ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry v3.7.0 was added to the version history, and the old v3.6.6 entry was removed, updating the page’s release history. This update affects only the log of revisions and does not alter substantive study information.SummaryDifference0.1%

- Check81 days agoChange DetectedA new release label Revision: v3.6.6 was added and the previous Revision: v3.6.5 was removed in the record history, reflecting an update to the page's revision listing rather than substantive study content.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.